Multiple-Dose Pharmacodynamics and Pharmacokinetics of Anacetrapib, a Potent Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Healthy Subjects

Rajesh Krishna, AJ Bergman, Bo Jin, Marissa S. Fallon, J Côté, Pascale Van Hoydonck, Tine Laethem, IN Gendrano, Kristien Van Dyck, D Hilliard,

Clinical Pharmacology & Therapeutics · 2008 · 99 citations · 16 references

Concepts

Abstract

Cholesteryl ester transfer protein (CETP) is a plasma protein that catalyzes the heteroexchange of cholesteryl esters from high-density lipoprotein (HDL) and triglycerides to apolipoprotein B–containing lipoproteins, especially very low–density lipoproteins (LDL-C).1,2 Clinical Pharmacology & Therapeutics (2008); 84, 6, 679–683 doi:10.1038/clpt.2008.109

References

16